(Reuters) - Endo International Plc on Monday gave a glimpse of a quarter that could help ease investor concerns when it announced preliminary earnings well above market estimates, sending the generic-drug maker's shares up as much as 18 percent.
from Reuters: Health News http://ift.tt/2hng52j
No comments:
Post a Comment